Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients
Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in the vascular endothelium. Soluble forms of the receptor for AGE (RAGE) may be protective against these effects by binding AGE in the soluble phase. Accu...
Gespeichert in:
| Veröffentlicht in: | International urology and nephrology 2012-08, Vol.44 (4), p.1201-1202 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1202 |
|---|---|
| container_issue | 4 |
| container_start_page | 1201 |
| container_title | International urology and nephrology |
| container_volume | 44 |
| creator | NasrAllah, Mohamed M. El-Shehaby, Amal R. Osman, Noha A. Salem, Mona M. Nassef, Amr El Din, Usama A. A. Sharaf |
| description | Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in the vascular endothelium. Soluble forms of the receptor for AGE (RAGE) may be protective against these effects by binding AGE in the soluble phase. Accumulating evidence suggests a protective role of soluble RAGE against vascular calcification. This study investigates the association between endogenous soluble RAGE (esRAGE) and vascular calcification in hemodialysis patients. We studied 65 non-diabetic hemodialysis patients, on 3 × 4 h dialysis schedule, and 19 controls. Serum levels of esRAGE, hsCRP, parathormone, lipids, calcium, and phosphorus were measured. Aortic calcification index (ACI) was measured using non-contrast CT of the abdominal aorta. Aortic calcification was detected in 64 out of 65 hemodialysis patients. Levels of esRAGE were lower in hemodialysis patients (278 pg/ml, SD 101.1) than in controls (443 ± 109 pg/ml; P = 0.001). ACI correlated negatively in stepwise multivariate analysis with esRAGE (P = 0.002) and positively with hsCRP ( |
| doi_str_mv | 10.1007/s11255-011-0067-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1027260928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2717472981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c274y-bad163046fef25b5f133f783d583e45963408409fcc05b61ccbf35b624d18adb3</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMoOK7-AG8BL3qIW0n6a7wty7guLAii5yadVGaz9CRjKj1L_yl_o1lmD148pQLP-xTFy9h7CZ8lQH9JUqq2FSClAOh6sb5gG9n2Wqh2aF6yDWiQQnZKv2ZviB4AYDsAbNifXc6mLAde0he-iy7tMaaFOKV5mWbkGS0eS8o8eW7cyUSLju_n1ZoSUuQYnTjm5BZbiH9E-nF1s_vEA_GI-0qccF65IUo2mFKDj6Hc85Mhu8wmc2tmG3x4VoXIY4rCBTNhCZbf4yHVz7xS1R0rg7HQW_bKm5nw3fN7wX593f28_ibuvt_cXl_dCav6ZhWTcbLT0HQevWqn1kutfT9o1w4am3bb6QaGBrbeWminTlo7eV0H1Tg5GDfpC_bh7K3H_V6QyviQlhzrylGC6lUHWzVUSp4pmxNRRj8ecziYvFZofKplPNcy1lrGp1rGtWbUOUOVjXvM_5r_F_oLvtmUpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1027260928</pqid></control><display><type>article</type><title>Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients</title><source>Springer Nature - Complete Springer Journals</source><creator>NasrAllah, Mohamed M. ; El-Shehaby, Amal R. ; Osman, Noha A. ; Salem, Mona M. ; Nassef, Amr ; El Din, Usama A. A. Sharaf</creator><creatorcontrib>NasrAllah, Mohamed M. ; El-Shehaby, Amal R. ; Osman, Noha A. ; Salem, Mona M. ; Nassef, Amr ; El Din, Usama A. A. Sharaf</creatorcontrib><description>Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in the vascular endothelium. Soluble forms of the receptor for AGE (RAGE) may be protective against these effects by binding AGE in the soluble phase. Accumulating evidence suggests a protective role of soluble RAGE against vascular calcification. This study investigates the association between endogenous soluble RAGE (esRAGE) and vascular calcification in hemodialysis patients. We studied 65 non-diabetic hemodialysis patients, on 3 × 4 h dialysis schedule, and 19 controls. Serum levels of esRAGE, hsCRP, parathormone, lipids, calcium, and phosphorus were measured. Aortic calcification index (ACI) was measured using non-contrast CT of the abdominal aorta. Aortic calcification was detected in 64 out of 65 hemodialysis patients. Levels of esRAGE were lower in hemodialysis patients (278 pg/ml, SD 101.1) than in controls (443 ± 109 pg/ml; P = 0.001). ACI correlated negatively in stepwise multivariate analysis with esRAGE (P = 0.002) and positively with hsCRP (<0.0001), systolic blood pressure (P < 0.0001) and dialysis vintage (P = 0.05); R (2) = 0.65. Levels of esRAGE were low among hemodialysis patients and correlated negatively with ACI.</description><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-011-0067-y</identifier><identifier>CODEN: IURNAE</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Erratum ; Medicine ; Medicine & Public Health ; Nephrology ; Urology</subject><ispartof>International urology and nephrology, 2012-08, Vol.44 (4), p.1201-1202</ispartof><rights>Springer Science+Business Media, B.V. 2011</rights><rights>Springer Science+Business Media, B.V. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c274y-bad163046fef25b5f133f783d583e45963408409fcc05b61ccbf35b624d18adb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11255-011-0067-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11255-011-0067-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>NasrAllah, Mohamed M.</creatorcontrib><creatorcontrib>El-Shehaby, Amal R.</creatorcontrib><creatorcontrib>Osman, Noha A.</creatorcontrib><creatorcontrib>Salem, Mona M.</creatorcontrib><creatorcontrib>Nassef, Amr</creatorcontrib><creatorcontrib>El Din, Usama A. A. Sharaf</creatorcontrib><title>Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><description>Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in the vascular endothelium. Soluble forms of the receptor for AGE (RAGE) may be protective against these effects by binding AGE in the soluble phase. Accumulating evidence suggests a protective role of soluble RAGE against vascular calcification. This study investigates the association between endogenous soluble RAGE (esRAGE) and vascular calcification in hemodialysis patients. We studied 65 non-diabetic hemodialysis patients, on 3 × 4 h dialysis schedule, and 19 controls. Serum levels of esRAGE, hsCRP, parathormone, lipids, calcium, and phosphorus were measured. Aortic calcification index (ACI) was measured using non-contrast CT of the abdominal aorta. Aortic calcification was detected in 64 out of 65 hemodialysis patients. Levels of esRAGE were lower in hemodialysis patients (278 pg/ml, SD 101.1) than in controls (443 ± 109 pg/ml; P = 0.001). ACI correlated negatively in stepwise multivariate analysis with esRAGE (P = 0.002) and positively with hsCRP (<0.0001), systolic blood pressure (P < 0.0001) and dialysis vintage (P = 0.05); R (2) = 0.65. Levels of esRAGE were low among hemodialysis patients and correlated negatively with ACI.</description><subject>Erratum</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>Urology</subject><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kU2LFDEQhoMoOK7-AG8BL3qIW0n6a7wty7guLAii5yadVGaz9CRjKj1L_yl_o1lmD148pQLP-xTFy9h7CZ8lQH9JUqq2FSClAOh6sb5gG9n2Wqh2aF6yDWiQQnZKv2ZviB4AYDsAbNifXc6mLAde0he-iy7tMaaFOKV5mWbkGS0eS8o8eW7cyUSLju_n1ZoSUuQYnTjm5BZbiH9E-nF1s_vEA_GI-0qccF65IUo2mFKDj6Hc85Mhu8wmc2tmG3x4VoXIY4rCBTNhCZbf4yHVz7xS1R0rg7HQW_bKm5nw3fN7wX593f28_ibuvt_cXl_dCav6ZhWTcbLT0HQevWqn1kutfT9o1w4am3bb6QaGBrbeWminTlo7eV0H1Tg5GDfpC_bh7K3H_V6QyviQlhzrylGC6lUHWzVUSp4pmxNRRj8ecziYvFZofKplPNcy1lrGp1rGtWbUOUOVjXvM_5r_F_oLvtmUpA</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>NasrAllah, Mohamed M.</creator><creator>El-Shehaby, Amal R.</creator><creator>Osman, Noha A.</creator><creator>Salem, Mona M.</creator><creator>Nassef, Amr</creator><creator>El Din, Usama A. A. Sharaf</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201208</creationdate><title>Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients</title><author>NasrAllah, Mohamed M. ; El-Shehaby, Amal R. ; Osman, Noha A. ; Salem, Mona M. ; Nassef, Amr ; El Din, Usama A. A. Sharaf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c274y-bad163046fef25b5f133f783d583e45963408409fcc05b61ccbf35b624d18adb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Erratum</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NasrAllah, Mohamed M.</creatorcontrib><creatorcontrib>El-Shehaby, Amal R.</creatorcontrib><creatorcontrib>Osman, Noha A.</creatorcontrib><creatorcontrib>Salem, Mona M.</creatorcontrib><creatorcontrib>Nassef, Amr</creatorcontrib><creatorcontrib>El Din, Usama A. A. Sharaf</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NasrAllah, Mohamed M.</au><au>El-Shehaby, Amal R.</au><au>Osman, Noha A.</au><au>Salem, Mona M.</au><au>Nassef, Amr</au><au>El Din, Usama A. A. Sharaf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients</atitle><jtitle>International urology and nephrology</jtitle><stitle>Int Urol Nephrol</stitle><date>2012-08</date><risdate>2012</risdate><volume>44</volume><issue>4</issue><spage>1201</spage><epage>1202</epage><pages>1201-1202</pages><issn>0301-1623</issn><eissn>1573-2584</eissn><coden>IURNAE</coden><abstract>Advanced glycation end-products (AGE) accumulate in CKD and may predispose to cardiovascular disease by inducing inflammatory and oxidant stress in the vascular endothelium. Soluble forms of the receptor for AGE (RAGE) may be protective against these effects by binding AGE in the soluble phase. Accumulating evidence suggests a protective role of soluble RAGE against vascular calcification. This study investigates the association between endogenous soluble RAGE (esRAGE) and vascular calcification in hemodialysis patients. We studied 65 non-diabetic hemodialysis patients, on 3 × 4 h dialysis schedule, and 19 controls. Serum levels of esRAGE, hsCRP, parathormone, lipids, calcium, and phosphorus were measured. Aortic calcification index (ACI) was measured using non-contrast CT of the abdominal aorta. Aortic calcification was detected in 64 out of 65 hemodialysis patients. Levels of esRAGE were lower in hemodialysis patients (278 pg/ml, SD 101.1) than in controls (443 ± 109 pg/ml; P = 0.001). ACI correlated negatively in stepwise multivariate analysis with esRAGE (P = 0.002) and positively with hsCRP (<0.0001), systolic blood pressure (P < 0.0001) and dialysis vintage (P = 0.05); R (2) = 0.65. Levels of esRAGE were low among hemodialysis patients and correlated negatively with ACI.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s11255-011-0067-y</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-1623 |
| ispartof | International urology and nephrology, 2012-08, Vol.44 (4), p.1201-1202 |
| issn | 0301-1623 1573-2584 |
| language | eng |
| recordid | cdi_proquest_journals_1027260928 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Erratum Medicine Medicine & Public Health Nephrology Urology |
| title | Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T20%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erratum%20to:%20Endogenous%20soluble%20receptor%20of%20advanced%20glycation%20end-products%20(esRAGE)%20is%20negatively%20associated%20with%20vascular%20calcification%20in%20non-diabetic%20hemodialysis%20patients&rft.jtitle=International%20urology%20and%20nephrology&rft.au=NasrAllah,%20Mohamed%20M.&rft.date=2012-08&rft.volume=44&rft.issue=4&rft.spage=1201&rft.epage=1202&rft.pages=1201-1202&rft.issn=0301-1623&rft.eissn=1573-2584&rft.coden=IURNAE&rft_id=info:doi/10.1007/s11255-011-0067-y&rft_dat=%3Cproquest_cross%3E2717472981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1027260928&rft_id=info:pmid/&rfr_iscdi=true |